Issued Patents All Time
Showing 1–15 of 15 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11292796 | Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors | Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Garrick Packard +7 more | 2022-04-05 |
| 10683298 | Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors | Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Garrick Packard +7 more | 2020-06-16 |
| 10167290 | Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors | Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Garrick Packard +7 more | 2019-01-01 |
| 9771371 | Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors | Jan Elsner, Roy L. Harris, Branden Lee, Deborah Mortensen, Garrick Packard +7 more | 2017-09-26 |
| 9193692 | Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors | Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Patrick Papa, Branden Lee +6 more | 2015-11-24 |
| 9079900 | Methods of synthesis and purification of heteroaryl compounds | Roy L. Harris, John Sapienza, Patrick Papa, Branden Lee, Garrick Packard +13 more | 2015-07-14 |
| 8907087 | Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors | Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Patrick Papa, Branden Lee +6 more | 2014-12-09 |
| 8569494 | Methods of synthesis and purification of heteroaryl compounds | Roy L. Harris, John Sapienza, Patrick Papa, Branden Lee, Garrick Packard +13 more | 2013-10-29 |
| 8507492 | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway | Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Patrick Papa, Branden Lee +12 more | 2013-08-13 |
| 8492381 | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway | Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Patrick Papa, Branden Lee +12 more | 2013-07-23 |
| 8372976 | Methods of treatment comprising the administration of heteroaryl compounds | Deborah Mortensen, Maria Mercedes Delgado Mederos, John Sapienza, Ronald Albers, Branden Lee +9 more | 2013-02-12 |
| 8110578 | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway | Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Patrick Papa, Branden Lee +12 more | 2012-02-07 |
| 7981893 | Heteroaryl compounds, compositions thereof, and methods of treatment therewith | Deborah Mortensen, Maria Mercedes Delgado Mederos, John Sapienza, Ronald Albers, Branden Lee +9 more | 2011-07-19 |
| 6372739 | Compounds and methods for modulation of estrogen receptors | Bernd Stein, David Wesley Anderson, Leah M. Gayo-Fung, Mary Doubleday, Adam Kois +4 more | 2002-04-16 |
| 6291456 | Compounds and methods for modulation of estrogen receptors | Bernd Stein, David Wesley Anderson, Leah M. Gayo-Fung, May S. Kung Sutherland, Mary Doubleday +5 more | 2001-09-18 |